Scientists just found a way to fight lung cancer and muscle wasting at the same time
ScienceDaily, relaying Oregon State University, reports a preclinical study in mice in which lipid nanoparticles carried follistatin mRNA to lung tumors. Compared with conventional nanoparticles that tend to collect in the liver, the approach achieved an approximately 2.5-fold greater reduction in tumor burden and helped preserve body weight and muscle in mice with cachexia. It has not been tested in people.
Why it matters: Relevant to Marylanders living with lung cancer or cancer-related muscle wasting, and to oncology and rehabilitation clinicians following early-stage cachexia research.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to sciencedaily.com. October 5, 2026.